搜索临床试验以:Mali
总计9360个结果
-
Dana-Farber Cancer InstituteMassachusetts General Hospital; Beth Israel Deaconess Medical Center; Brigham and Women's Hospital 和其他合作者完全的胶质母细胞瘤 | 胶质肉瘤 | 恶性胶质瘤美国
-
Bristol-Myers Squibb终止
-
Bristol-Myers Squibb完全的HER2 or EGFR Expressing Advanced Solid Malignancies西班牙, 法国
-
Virginia Commonwealth UniversityNational Cancer Institute (NCI)完全的
-
Catholic University of the Sacred HeartPagano L, Aversa F, Locatelli F, Nosari A,Rossi G, Viale P完全的
-
Envita Medical Center, Inc.暂停胶质瘤 | 乳腺癌 | 胰腺癌 | 前列腺癌 | 结肠癌 | 肝细胞癌 | 鳞状细胞肺癌美国
-
Kliniken Ludwigsburg-Bietigheim gGmbHKlinikum Ludwigshafen; Universitätsmedizin Mannheim未知To Evaluate Patency of the Viaduct Stent in Comparison to Metal Stents德国
-
AstraZeneca撤销
-
Norpharma A/SMundipharma Finland完全的
-
Heidelberg University完全的
-
University of Medicine and Dentistry of New JerseyNational Cancer Institute (NCI)终止淋巴瘤 | 骨髓增生异常综合征 | 白血病 | 慢性骨髓增生性疾病 | 多发性骨髓瘤和浆细胞肿瘤 | 骨髓增生异常/骨髓增生性疾病 | 癌前/非恶性疾病美国
-
Kentuckiana Cancer InstituteEisai Inc.未知
-
Kentuckiana Cancer InstituteEisai Inc.未知
-
Memorial Sloan Kettering Cancer Center完全的
-
National Taiwan University Hospital撤销
-
University of LiegeKU Leuven; Amgen; Vrije Universiteit Brussel完全的
-
Fujian Longhua Pharmaceutical Co. LtdSun Yat-sen University; Fuzhou University未知
-
City of Hope Medical CenterNational Cancer Institute (NCI)完全的
-
Royal Marsden NHS Foundation TrustInstitute of Cancer Research, United Kingdom未知
-
Novartis Pharmaceuticals终止
-
Novartis Pharmaceuticals完全的
-
Wyeth is now a wholly owned subsidiary of PfizerPETHEMA (Program for the Study and Treatment of Haematological Malignances)完全的
-
Royal Marsden NHS Foundation Trust未知
-
Pediatric Brain Tumor ConsortiumNational Cancer Institute (NCI)终止
-
Pediatric Brain Tumor ConsortiumNational Cancer Institute (NCI)完全的
-
Nordic Society for Pediatric Hematology and OncologyDanish Child Cancer Foundation; Medac, Hamburg, Germany未知
-
Rigshospitalet, Denmark完全的